NovaBone Products, which develops bone graft substitutes based on advancements in biomedical engineering that meet the specialized needs of orthopedic and dental surgeons, has opened a new 3,500 square foot dedicated R&D facility in Gainesville, Florida.
The new facility provides a platform for NovaBone Products to implement its product development strategy.
The company has recently named Gregory Pomrink as VP of R&D.
Prior to joining NovaBone Products, Pomrink worked at Orthovita, Dentsply and Integra LifeSciences.
President Art Wotiz said Pomrink has the perfect background and experience to help NovaBone Products continue to grow sales at 50+% per year and in fact, they have already seen breakthrough progress on key projects with their bioactive bone graft.